These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16443426

  • 1. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes.
    Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK, White A, Gibson JM, Brismar K.
    Am J Med; 2006 Feb; 119(2):167.e9-15. PubMed ID: 16443426
    [Abstract] [Full Text] [Related]

  • 2. Serum insulin, IGF-I,IGF-II and growth hormone, and left ventricular mass in noninsulin-dependent mellitus.
    Rabkin SW, Dawson KG, Bhaumick B, O'Brein E, Kendler DL.
    Can J Cardiol; 1996 Mar; 12(3):264-70. PubMed ID: 8624976
    [Abstract] [Full Text] [Related]

  • 3. Effects of insulin and sulphonylureas on insulin-like growth factor-I levels in streptozotocin-induced diabetic rats.
    Guney E, Kisakol G, Oge A, Yilmaz C, Kabalak T.
    Neuro Endocrinol Lett; 2002 Mar; 23(5-6):437-9. PubMed ID: 12500166
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [Abstract] [Full Text] [Related]

  • 5. Weight changes following the initiation of new anti-hyperglycaemic therapies.
    Nichols GA, Gomez-Caminero A.
    Diabetes Obes Metab; 2007 Jan; 9(1):96-102. PubMed ID: 17199724
    [Abstract] [Full Text] [Related]

  • 6. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.
    Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Rosen CJ, Lanza E, Schatzkin A.
    Eur J Clin Nutr; 2008 Feb; 62(2):186-96. PubMed ID: 17487212
    [Abstract] [Full Text] [Related]

  • 7. [Effects of L-arginine on the expression of insulin-like growth factors and insulin-like growth factor binding protein 3 in rats with intrauterine growth retardation].
    Lu Y, Liu XM, Li SQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):319-22. PubMed ID: 16923367
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Development of body weight during antidiabetic treatment].
    Hamann A.
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S255-8. PubMed ID: 17139582
    [Abstract] [Full Text] [Related]

  • 10. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory cytokines in insulin-treated patients with type 2 diabetes.
    Mavridis G, Souliou E, Diza E, Symeonidis G, Pastore F, Vassiliou AM, Karamitsos D.
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):471-6. PubMed ID: 17976964
    [Abstract] [Full Text] [Related]

  • 12. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A, Lüddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L, PREDICTIVE Study Group.
    Int J Clin Pract; 2008 Apr; 62(4):659-65. PubMed ID: 18324957
    [Abstract] [Full Text] [Related]

  • 13. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

  • 14. Treatment with insulin glargine does not suppress serum IGF-1.
    Slawik M, Schories M, Busse Grawitz A, Reincke M, Petersen KG.
    Diabet Med; 2006 Jul; 23(7):814-7. PubMed ID: 16842489
    [Abstract] [Full Text] [Related]

  • 15. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E, Giavoli C, Porretti S, Vassallo E, Ronchi CL, Lania AG, Beck-Peccoz P, Spada A.
    Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
    [Abstract] [Full Text] [Related]

  • 17. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T.
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [Abstract] [Full Text] [Related]

  • 18. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.
    Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [Abstract] [Full Text] [Related]

  • 20. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM.
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.